Intervention to reduce alcohol use in young people with early phase psychosis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to pilot cognitive enhancement therapy (CET) for individuals aged 16-35 with early phase psychosis (EPP) who also have problematic alcohol use. Participants will be randomized to receive either CET or standard treatment, which includes brief psychoeducation about substance use. The study will assess clinical outcomes as well as social determinants of health, such as return to school or work, to evaluate the effectiveness of the intervention. By focusing on both clinical and social recovery metrics, the study seeks to provide a comprehensive understanding of the impact of alcohol on recovery from psychosis.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* This study will enroll individuals 16-35 years of age from Early Intervention Services for Psychosis in Nova Scotia
* less than 5 years of psychotic illness.
* Individuals will have a psychotic spectrum diagnosis (primary psychotic disorder) that will include schizophrenia, schizoaffective disorder, and unspecified schizophrenia spectrum disorder.
* have problematic alcohol use (score of 8 or higher on the World Health Organization Alcohol Use Disorders Identification Test (WHO-AUDIT))

Exclusion Criteria:

* presence of another substance use disorder other than nicotine dependence

Where it's running

• Nova Scotia Health Authority
  Halifax, Nova Scotia, Canada Recruiting

Study contacts

• Principal investigator: Philip G Tibbo, MD — Nova Scotia Health Authority
• Study coordinator: Candice E Crocker, PhD
• Email: Candice.Crocker@nshealth.ca
• Phone: 902-473-3755

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Action-based cognitive remediation for alcohol and cannabis misuse in early psychosis

  This project will test whether action-based cognitive remediation helps young people with early psychosis cut down on alcohol and cannabis use.

  Recruiting at 2 sites Nova Scotia Health Authority · St. John's, Newfoundland and Labrador and 1 other locations · NCT07056894

• New blood test to help identify and track depression and early schizophrenia

  This project will try a new blood test to see if it can identify and track depression or early schizophrenia in adults receiving psychiatric care.

  Recruiting Fraser Health · New Westminster, British Columbia · NCT06856161

• Examining the effects of combined therapy for schizophrenia

  This study is testing whether combining two therapies, one for managing thoughts and another for improving cognitive skills, can help people with schizophrenia do better in their daily lives compared to using just one of the therapies.

  Recruiting at 2 sites University of Toronto · Scarborough Village, Ontario and 1 other locations · NCT05731414

• Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures

  This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.

  Recruiting Université Catholique de Louvain · Brussels, Belgium · NCT07925281

• Thiamine to reduce brain injury in adults with alcohol use disorder

  This trial tests whether thiamine can help protect the brain in adults with moderate to severe alcohol use disorder who drink daily.

  Recruiting Phase 2 Institut National de la Santé Et de la Recherche Médicale, France · Paris, Île-de-France Region · NCT07844720

• State Representation in Early Psychosis 2

  This observational study tests how people with early psychosis and healthy individuals use state information during tasks and how brain activity supports it.

  Recruiting at 2 sites University of Minnesota · Minneapolis, Minnesota and 1 other locations · NCT07834203

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.